You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Profile for Lithuania Patent: 2943185


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Lithuania Patent: 2943185

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 8, 2034 Almatica LOREEV XR lorazepam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Analysis for Lithuania Drug Patent LT2943185

Last updated: February 20, 2026

What is the scope of patent LT2943185?

Patent LT2943185, granted in Lithuania, covers a pharmaceutical compound or formulation with an explicit focus on [specific drug class or active ingredient, if available]. Although detailed claims are not publicly disclosed in the abstract, typical scope elements include:

  • Active Ingredient(s): The patent claims encompass the chemical structure of the molecule, including salts and derivatives.
  • Formulation: Claims extend to specific pharmaceutical formulations, such as tablets, capsules, or injectable forms.
  • Use: Therapeutic methods facilitated by the compound, including indications for treating [specific diseases or conditions].
  • Manufacturing Process: Claims may detail the synthesis or purification method for producing the compound.

The patent generally aims to protect the chemical core, specific formulations, or therapeutic use, depending on the original filing strategy. The central claims likely restrict competitors from making, using, or selling similar compounds or formulations within the patent's lifetime.

How broad are the patent claims?

The breadth of the claims determines potential competitor freedom-to-operate:

  • Chemical Structure Claims: If broad, they cover all derivatives within a chemical class or substructure. Narrow claims may only cover specific compounds.
  • Method Claims: Cover specific treatment protocols or manufacturing processes.
  • Formulation Claims: Could encompass multiple dosage forms and excipient combinations.

Without access to the full patent text and claims, the typical scope for pharmaceutical patents includes both compound-specific claims and use-method claims. The patent probably has a combination of narrow and broad claims, balancing protection with potential for carve-outs or workarounds.

What does the patent landscape for LT2943185 look like?

The patent landscape includes three key areas:

1. Active Ingredient Patents

Other patents may cover the core molecule or similar derivatives. International patents filed through major jurisdictions (EPO, USPTO, China) could give broader protection. Patent families often include claims covering identical or similar chemical entities.

2. Formulation and Delivery Patents

Patents related to specific formulations, controlled-release systems, or delivery methods. These can extend patent life beyond compound patents, especially if formulation improvements are novel.

3. Use and Method Patents

Patents claiming novel indications or treatment methods, which can block off-label uses or methods of administration. They often extend the protective landscape beyond chemical patents.

Comparative Landscape:

Patent Type Typical Scope Public Examples
Core structure patents Structural claims, derivatives Often have narrow claims
Formulation patents Dosage forms, excipient combinations Vary in scope, sometimes broad
Use/method patents Treatment methods, indications Can be broad or narrow

Patent Family & Priority Data

  • Several families may extend protection to multiple jurisdictions.
  • Priority date complexity influences patent strength and potential infringement assessments.

Related patents and potential conflicts

  • Patent conflicts arise if other patents claim similar structures or formulations.
  • The presence of overlapping patent families could limit market entry.
  • Patent term extensions or supplementary protection certificates may prolong exclusivity.

Legal status and expiration

  • Patent LT2943185's expiration depends on its filing date and maintenance payments.
  • If filed prior to 2005 (local law), 20 years from the priority date applies.
  • Monitoring for challenges or oppositions can impact enforceability.

Strategic considerations

  • Patent scope influences R&D direction and licensing.
  • Narrow claims suggest competitors might develop around the patent.
  • Broad claims offer more defensible exclusivity but can trigger challenges.

Key Takeaways

  1. Scope: Likely covers the chemical compound, specific formulations, or therapeutic uses, but precise claims need review.
  2. Landscape: Patent families across jurisdictions may extend protection beyond Lithuania.
  3. Strength: Broad formulation or use claims typically extend market exclusivity.
  4. Infringements: Licensing opportunities depend on patent claim breadth and existing patent overlap.

FAQs

Q1: How can I access the full patent claims for LT2943185?
A1: The full claims are available through Lithuanian Patent Office or international patent databases such as Espacenet or WIPO World Patent Database.

Q2: How does the scope of patent claims impact generic development?
A2: Narrow claims allow generic companies to design around the patent, while broad claims restrict alternative formulations or uses.

Q3: Can patents in other jurisdictions threaten the exclusivity of LT2943185 in Lithuania?
A3: Yes. Patents filed in major markets can extend patent protection or provide blocking rights if they cover similar compounds or formulations.

Q4: What strategies can extend the patent life beyond the initial term?
A4: Formulation improvements, new uses, or method claims can create secondary patents extending market exclusivity.

Q5: What legal steps are involved in challenging a patent like LT2943185?
A5: Legal challenges include opposition proceedings, validity disputes, or patent revocation based on prior art or non-obviousness.


References

  1. European Patent Office. (2022). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com
  2. World Intellectual Property Organization. (2023). PATENTSCOPE. Retrieved from https://patentscope.wipo.int
  3. Lithuanian Patent Office. (2023). Patent database. Retrieved from https://vbi.lt

[1] European Patent Office. (2022). Espacenet Patent Search.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.